Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients
Clinical trial NCT03053856 · UNKNOWN
Trial details
- NCT number
- NCT03053856
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2021-05-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.